Association of CXCR4 Expression with Metastasis and Survival among Patients with Non-small Cell Lung Cancer
2
조회
0
다운로드
1
인용
0
참고문헌
초록
Background : Expression of CXCR4 chemokine receptor, initially described to be involved in the homing of lymphocytes in inflammatory tissue, on breast cancer cell lines is associated with the development of lung metastases. In the present study, we evaluated CXCR4 expression in patients with non-small cell lung cancer (NSCLC). Methods : Tissue microarray blocks were constructed from 408 formalin-fixed, paraffin-embedded NSCLC samples and analyzed via immunohistochemical staining. Results : We observed CXCR4 expression in 214 (66.3%) of the 323 tumors with cytoplasmic or nuclear staining patterns. These tumors were then divided into 109 negative, 166 weak-positive and 48 strong-positive expression groups. Strong expression of CXCR4 correlated with NSCLC recurrence (p=0.047) and distant metastasis (p=0.035). However, lymph node metastasis (p=0.683) and locoregional recurrence (p=0.856) were not associated with CXCR4 expression. Interestingly, the median overall survival times relative to CXCR4 expression were 71 months in the CXCR4-negative group, 43 months in the weakly positive CXCR4 group and 23 months in the strongly positive CXCR4 group. Strongly positive CXCR4 staining was associated with significantly worse outcomes (p=0.005, log-rank test). Conclusions : Expression of CXCR4 was associated with distant NSCLC metastases and shorter survival times.
Abstract
Background : Expression of CXCR4 chemokine receptor, initially described to be involved in the homing of lymphocytes in inflammatory tissue, on breast cancer cell lines is associated with the development of lung metastases. In the present study, we evaluated CXCR4 expression in patients with non-small cell lung cancer (NSCLC). Methods : Tissue microarray blocks were constructed from 408 formalin-fixed, paraffin-embedded NSCLC samples and analyzed via immunohistochemical staining. Results : We observed CXCR4 expression in 214 (66.3%) of the 323 tumors with cytoplasmic or nuclear staining patterns. These tumors were then divided into 109 negative, 166 weak-positive and 48 strong-positive expression groups. Strong expression of CXCR4 correlated with NSCLC recurrence (p=0.047) and distant metastasis (p=0.035). However, lymph node metastasis (p=0.683) and locoregional recurrence (p=0.856) were not associated with CXCR4 expression. Interestingly, the median overall survival times relative to CXCR4 expression were 71 months in the CXCR4-negative group, 43 months in the weakly positive CXCR4 group and 23 months in the strongly positive CXCR4 group. Strongly positive CXCR4 staining was associated with significantly worse outcomes (p=0.005, log-rank test). Conclusions : Expression of CXCR4 was associated with distant NSCLC metastases and shorter survival times.
참고문헌 (30)
- Fidler IJ., "Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture", Cancer Res, 50, pp.6130~6138 (1990)
- Fidler IJ., "Critical determinants of cancer metastasis: rationale for therapy", Cancer Chemother Pharmacol, 43, pp.3~10 (1999)
- Strieter RM., "Chemokines: not just leukocyte chemoattractants in the promotion of cancer", Nat Immunol, 2, pp.285~286 (2001)
- Rossi D, "The biology of chemokines and their receptors", Annu Rev Immunol, 18, pp.217~242 (2000)
- Premack BA, "Chemokine receptors: gateways to inflammation and infection", Nat Med, 2, pp.1174~1178 (1996)
- Baggiolini M., "Chemokines and leukocyte traffic", Nature, 392, pp.565~568 (1998)
- Koizumi K, "Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response", Cancer Sci, 98, pp.1652~1658 (2007)
- Power CA, "Cloning and characterization of human chemokine receptors", Trends Pharmacol Sci, 17, pp.209~213 (1996)
- Luster AD., "Chemokines--chemotactic cytokines that mediate inflammation", N Engl J Med, 338, pp.436~445 (1998)
- Paget S., "The distribution of secondary growths in cancer of the breast. 1889", Cancer Metastasis Rev, 8, pp.98~101 (1889)
- Muller A, "Involvement of chemokine receptors in breast cancer metastasis", Nature, 410, pp.50~56 (2001)
- Travis WD, "Pathology and genetics of tumors of the lung, pleura, thymus and heart", pp.10~ (2004), IARCPress
- Balkwill F., "The significance of cancer cell expression of the chemokine receptor CXCR4", Semin Cancer Biol, 14, pp.171~179 (2004)
- Scotton CJ, "Epithelial cancer cell migration: a role for chemokine receptors?", Cancer Res, 61, pp.4961~4965 (2001)
- Sun YX, "Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo", J Cell Biochem, 89, pp.462~473 (2003)
- Shibuta K, "Regional expression of CXCL12", CXCR4 in liver and hepatocellular carcinoma and cell-cycle variation during in vitro differentiation, 2002, pp.93, 789~797
- Shim H, "Lower expression of CXCR4 in lymph node metastases than in primary breast cancers: potential regulation by ligand-dependent degradation and HIF-1alpha", Biochem Biophys Res Commun, 346, pp.252~258 (2006)
- Kato M, "Expression pattern ofCXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma", Breast Cancer Res, 5, pp.144~150 (2003)
- Wang N, "Expression of chemokine receptor CXCR4 in nasopharyngeal carcinoma: pattern of expression and correlation with clinical outcome", J Transl Med, 3, pp.26~ (2005)
- Yoshitake N, "Expression of SDF-1 alpha and nuclear CXCR4 predicts lymph node metastasis in colorectal cancer", Br J Cancer, 98, pp.1682~1689 (2008)
- Jordan NJ, "Expression of functional CXCR4 chemokine receptors on human colonic epithelial cells", J Clin Invest, 104, pp.1061~1069 (1999)
- Spano JP, "Chemokine receptor CXCR4 and early-stage non-small cell lung cancer: pattern of expression and correlation with outcome", Ann Oncol, 15, pp.613~617 (2004)
- Burger M, "Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells", Oncogene, 22, pp.8093~8101 (2003)
- Zeelenberg IS, "The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases", Cancer Res, 63, pp.3833~3839 (2003)
- Pouyssegur J, "Hypoxia signalling in cancer and approaches to enforce tumour regression", Nature, 441, pp.437~443 (2006)
- Taichman RS, "Use of the stromal cell-derived factor-1", CXCR4 pathway in prostate cancer metastasis to bone, 2002, pp.62, 1832~1837
- Oonakahara K, "Stromal-derived factor-1alpha", CXCL12-CXCR 4 axis is involved in the dissemination of NSCLC cells into pleural space, 2004, pp.30, 671~677
- Ottaiano A, "Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients", Clin Cancer Res, 12, pp.2795~2803 (2006)
- Koishi K, "Persistent CXCR4 expression after preoperative chemoradiotherapy predicts early recurrence and poor prognosis in esophageal cancer", World J Gastroenterol, 12, pp.7585~7590 (2006)
- Holm NT, "Elevated chemokine receptor CXCR4 expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for patients with locally advanced breast cancer (LABC)", Breast Cancer Res Treat (2008)